The University of Manchester (UoM) bid for phase III of MRC Confidence in Concept funding

Lead Research Organisation: The University of Manchester
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding.  It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.

Publications

10 25 50
publication icon
Bland AR (2016) EMOTICOM: A Neuropsychological Test Battery to Evaluate Emotion, Motivation, Impulsivity, and Social Cognition. in Frontiers in behavioral neuroscience

publication icon
Bland AR (2017) Cooperative Behavior in the Ultimatum Game and Prisoner's Dilemma Depends on Players' Contributions. in Frontiers in psychology

publication icon
Dam VH (2019) Psychometric Properties and Validation of the EMOTICOM Test Battery in a Healthy Danish Population. in Frontiers in psychology

publication icon
Evangelou K (2017) Robust, universal biomarker assay to detect senescent cells in biological specimens. in Aging cell

publication icon
Hamilton P (2018) Peptide GAM immunoadsorption therapy in primary membranous nephropathy (PRISM): Phase II trial investigating the safety and feasibility of peptide GAM immunoadsorption in anti-PLA2 R positive primary membranous nephropathy. in Journal of clinical apheresis

publication icon
Hodgkinson T (2019) Therapeutic potential of growth differentiation factors in the treatment of degenerative disc diseases. in JOR spine

publication icon
Hodgkinson T (2020) Regenerative Response of Degenerate Human Nucleus Pulposus Cells to GDF6 Stimulation. in International journal of molecular sciences

publication icon
Hodgkinson T (2019) Microparticles for controlled growth differentiation factor 6 delivery to direct adipose stem cell-based nucleus pulposus regeneration. in Journal of tissue engineering and regenerative medicine

publication icon
Larkin S (2016) Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study in British Journal of Cancer

publication icon
Owens GL (2017) Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen. in Cancer medicine